Target72 kDa type IV collagenase(Homo sapiens (Human))
Procter And Gamble Pharmaceuticals
Curated by ChEMBL
Procter And Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 0.600nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-2More data for this Ligand-Target Pair
Affinity DataIC50: 0.800nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-13More data for this Ligand-Target Pair
Affinity DataIC50: 1nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-13More data for this Ligand-Target Pair
Target72 kDa type IV collagenase(Homo sapiens (Human))
Procter And Gamble Pharmaceuticals
Curated by ChEMBL
Procter And Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-2More data for this Ligand-Target Pair
Target72 kDa type IV collagenase(Homo sapiens (Human))
Procter And Gamble Pharmaceuticals
Curated by ChEMBL
Procter And Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 3nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-2More data for this Ligand-Target Pair
Target72 kDa type IV collagenase(Homo sapiens (Human))
Procter And Gamble Pharmaceuticals
Curated by ChEMBL
Procter And Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 5nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-2More data for this Ligand-Target Pair
Target72 kDa type IV collagenase(Homo sapiens (Human))
Procter And Gamble Pharmaceuticals
Curated by ChEMBL
Procter And Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 5nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-2More data for this Ligand-Target Pair
Target72 kDa type IV collagenase(Homo sapiens (Human))
Procter And Gamble Pharmaceuticals
Curated by ChEMBL
Procter And Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 6nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-2More data for this Ligand-Target Pair
Target72 kDa type IV collagenase(Homo sapiens (Human))
Procter And Gamble Pharmaceuticals
Curated by ChEMBL
Procter And Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 7nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-2More data for this Ligand-Target Pair
Affinity DataIC50: 7nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-13More data for this Ligand-Target Pair
Target72 kDa type IV collagenase(Homo sapiens (Human))
Procter And Gamble Pharmaceuticals
Curated by ChEMBL
Procter And Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 7nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-2More data for this Ligand-Target Pair
Target72 kDa type IV collagenase(Homo sapiens (Human))
Procter And Gamble Pharmaceuticals
Curated by ChEMBL
Procter And Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 8nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-2More data for this Ligand-Target Pair
Target72 kDa type IV collagenase(Homo sapiens (Human))
Procter And Gamble Pharmaceuticals
Curated by ChEMBL
Procter And Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 8nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-2More data for this Ligand-Target Pair
Affinity DataIC50: 8nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-13More data for this Ligand-Target Pair
Target72 kDa type IV collagenase(Homo sapiens (Human))
Procter And Gamble Pharmaceuticals
Curated by ChEMBL
Procter And Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 9nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-2More data for this Ligand-Target Pair
Target72 kDa type IV collagenase(Homo sapiens (Human))
Procter And Gamble Pharmaceuticals
Curated by ChEMBL
Procter And Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 9nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-2More data for this Ligand-Target Pair
Target72 kDa type IV collagenase(Homo sapiens (Human))
Procter And Gamble Pharmaceuticals
Curated by ChEMBL
Procter And Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 10nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-2More data for this Ligand-Target Pair
Affinity DataIC50: 11nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-13More data for this Ligand-Target Pair
Affinity DataIC50: 11nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-13More data for this Ligand-Target Pair
Target72 kDa type IV collagenase(Homo sapiens (Human))
Procter And Gamble Pharmaceuticals
Curated by ChEMBL
Procter And Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 12nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-2More data for this Ligand-Target Pair
Target72 kDa type IV collagenase(Homo sapiens (Human))
Procter And Gamble Pharmaceuticals
Curated by ChEMBL
Procter And Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 12nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-2More data for this Ligand-Target Pair
Affinity DataIC50: 13nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-13More data for this Ligand-Target Pair
Affinity DataIC50: 13nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-13More data for this Ligand-Target Pair
Target72 kDa type IV collagenase(Homo sapiens (Human))
Procter And Gamble Pharmaceuticals
Curated by ChEMBL
Procter And Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 13nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-2More data for this Ligand-Target Pair
Target72 kDa type IV collagenase(Homo sapiens (Human))
Procter And Gamble Pharmaceuticals
Curated by ChEMBL
Procter And Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 14nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-2More data for this Ligand-Target Pair
Target72 kDa type IV collagenase(Homo sapiens (Human))
Procter And Gamble Pharmaceuticals
Curated by ChEMBL
Procter And Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 15nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-2More data for this Ligand-Target Pair
Affinity DataIC50: 16nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-13More data for this Ligand-Target Pair
Affinity DataIC50: 17nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-13More data for this Ligand-Target Pair
Affinity DataIC50: 17nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-13More data for this Ligand-Target Pair
Target72 kDa type IV collagenase(Homo sapiens (Human))
Procter And Gamble Pharmaceuticals
Curated by ChEMBL
Procter And Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 17nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-2More data for this Ligand-Target Pair
Affinity DataIC50: 21nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-13More data for this Ligand-Target Pair
Affinity DataIC50: 21nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-13More data for this Ligand-Target Pair
Affinity DataIC50: 21nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-13More data for this Ligand-Target Pair
Affinity DataIC50: 22nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-13More data for this Ligand-Target Pair
Affinity DataIC50: 26nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-13More data for this Ligand-Target Pair
Affinity DataIC50: 26nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-3More data for this Ligand-Target Pair
Affinity DataIC50: 29nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-13More data for this Ligand-Target Pair
Affinity DataIC50: 32nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-13More data for this Ligand-Target Pair
Affinity DataIC50: 36nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-13More data for this Ligand-Target Pair
Affinity DataIC50: 37nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-13More data for this Ligand-Target Pair
Target72 kDa type IV collagenase(Homo sapiens (Human))
Procter And Gamble Pharmaceuticals
Curated by ChEMBL
Procter And Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 41nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-2More data for this Ligand-Target Pair
Affinity DataIC50: 43nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-13More data for this Ligand-Target Pair
Target72 kDa type IV collagenase(Homo sapiens (Human))
Procter And Gamble Pharmaceuticals
Curated by ChEMBL
Procter And Gamble Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 47nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-2More data for this Ligand-Target Pair
Affinity DataIC50: 54nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-13More data for this Ligand-Target Pair
Affinity DataIC50: 64nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-13More data for this Ligand-Target Pair
Affinity DataIC50: 67nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-13More data for this Ligand-Target Pair
Affinity DataIC50: 81nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-13More data for this Ligand-Target Pair
Affinity DataIC50: 98nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-3More data for this Ligand-Target Pair
Affinity DataIC50: 100nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-13More data for this Ligand-Target Pair
Affinity DataIC50: 200nMAssay Description:In vitro inhibitory concentration of the compound against Matrix metalloproteinase-13More data for this Ligand-Target Pair